Download PDF

Other users also viewed these articles

Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases Íñigo Rúa-Figueroa Fernández de Larrinoa; Patricia E. Carreira; Noé Brito García; Petra Díaz del Campo Fontecha; José María Pego Reigosa; José A. Gómez Puerta; Rafaela Ortega-Castro; Beatriz Tejera Segura; José María Aguado García; Julián Torre-Cisneros; José L. Valencia-Martín; Claudia Alejandra Pereda; María Betina Nishishinya-Aquino; María Teresa Otón Sánchez; Lucía Silva Fernández; Jesús Maese Manzano; Eugenio Chamizo Carmona; María Correyero Plaza;
Reumatol Clin. 2022;18:317-30
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41